Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.Published in:Thyroid, 2022, v. 32, n. 5, p. 821, doi. 10.1089/thy.2020.0269By:Vannucchi, Guia;Campi, Irene;Covelli, Danila;Currò, Nicola;Lazzaroni, Elisa;Palomba, Andrea;Soranna, Davide;Zambon, Antonella;Fugazzola, Laura;Muller, Ilaria;Guastella, Claudio;Salvi, MarioPublication type:Article